Graves Ophthalmopathy Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Graves Ophthalmopathy
  • Bimatoprost Ophthalmic
  • Seattle, Washington
    University of Washington
2022-03-08
Mar 8, 2022
V
Not yet recruiting
  • Thyroid Eye Disease
  • +11 more
  • (no location specified)
2022-03-02
Mar 2, 2022
U
Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
2022-02-17
Feb 17, 2022
T
Active, not recruiting
  • Graves Ophthalmopathy
  • Aarhus C, Central Denmark Region, Denmark
  • +1 more
2022-02-21
Feb 21, 2022
N
Not yet recruiting
  • Graves Ophthalmopathy
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-11-16
Nov 16, 2021
L
Recruiting
  • Graves Ophthalmopathy
  • +2 more
  • Simvastatin 40mg
  • Malmö, Sweden
    Dpt. of Endocrinology, SUS Malmö
2021-11-17
Nov 17, 2021
S
Recruiting
  • Graves Ophthalmopathy
  • +8 more
  • Doxycycline hyclate
  • Placebo
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
2021-11-16
Nov 16, 2021
S
Not yet recruiting
  • Strabismus, Mechanical
  • Graves Ophthalmopathy
  • supramaximal rectus recession
  • normal rectus recession
  • (no location specified)
2021-06-15
Jun 15, 2021
F
Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
2021-05-07
May 7, 2021
U
Recruiting
  • Exophthalmos
  • +3 more
  • Exophthalmos measurement
  • Zurich, Switzerland
    Ophthalmology Department, University Hospital Zurich
2021-01-10
Jan 10, 2021
G
Terminated
  • Graves Ophthalmopathy
  • Otelixizumab - low dose
  • +5 more
  • Newcastle upon Tyne, United Kingdom
    GSK Investigational Site
2020-10-08
Oct 8, 2020
U
Completed
  • Graves Ophthalmopathy
  • No Intervention
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
2020-07-22
Jul 22, 2020
M
Completed
  • Graves Disease
  • +5 more
  • Intravenous Methylprednisolone
  • (no location specified)
2020-05-13
May 13, 2020
U
Completed
  • Graves Ophthalmopathy
  • Orbital decompression
  • São Paulo, Brazil
    University of Sao Paulo General Hospital
2019-08-11
Aug 11, 2019
M
Completed
  • Graves Disease
  • +13 more
  • every week IVMP therapy
  • very high doses IVMP therapy
  • (no location specified)
2018-09-11
Sep 11, 2018
U
Completed
  • Graves Ophthalmopathy
  • +2 more
  • Serum antibodies against the IGF-1R
  • Pisa, Italy
    Endocrinology Unit I, University of Pisa
2018-07-26
Jul 26, 2018
M
Completed
  • Graves Disease
  • +4 more
  • (no location specified)
2018-07-17
Jul 17, 2018
P
Completed
  • Graves' Disease
  • +3 more
  • (no location specified)
2018-05-12
May 12, 2018
U
Completed
  • Graves Ophthalmopathy
  • No intervention
  • (no location specified)
2018-02-09
Feb 9, 2018
N
Unknown status
  • Graves Ophthalmopathy
    • Taipei, Taiwan
      National Taiwan University Hospital Taipei, Taiwan
    2017-10-29
    Oct 29, 2017
    R
    Withdrawn
    • Graves Ophthalmopathy
    • (no location specified)
    2017-04-25
    Apr 25, 2017
    M
    Unknown status
    • Graves Disease
    • +2 more
    • Antithyroid Drug
    • Total thyroidectomy
    • Vienna, Austria
      Department of Surgery and Department of Ophthalmology Medical Un
    2017-02-22
    Feb 22, 2017
    U
    Withdrawn
    • Graves Ophthalmopathy
    • Botulinum Toxin Type A
    • Saline injection
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    2015-06-02
    Jun 2, 2015
    U
    Unknown status
    • Graves Ophthalmopathy
    • External beam radiotherapy
    • intravenous corticosteroids (methylprednisolone)
    • (no location specified)
    2015-01-14
    Jan 14, 2015
    S
    Completed
    • Graves Ophthalmopathy
    • +8 more
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    2013-12-07
    Dec 7, 2013